Quinn RJ - Search Results

1

Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat.

Harden FA, Brown L, Quinn RJ, Harrison GJ, Headrick JP, Rose'Meyer RB, Willis RJ. Harden FA, et al. Among authors: quinn rj. Arzneimittelforschung. 2002;52(3):175-81. doi: 10.1055/s-0031-1299876. Arzneimittelforschung. 2002. PMID: 11963644

2

Critical micelle concentration and hemolytic activity--a correlation suggested by the marine sterol, halistanol trisulfate.

Moni RW, Parsons PG, Quinn RJ, Willis RJ. Moni RW, et al. Among authors: quinn rj. Biochem Biophys Res Commun. 1992 Jan 15;182(1):115-20. doi: 10.1016/s0006-291x(05)80119-6. Biochem Biophys Res Commun. 1992. PMID: 1731774

3

Synthesis and adenosine receptor affinity of a series of pyrazolo[3,4-d]pyrimidine analogues of 1-methylisoguanosine.

Harden FA, Quinn RJ, Scammells PJ. Harden FA, et al. Among authors: quinn rj. J Med Chem. 1991 Sep;34(9):2892-8. doi: 10.1021/jm00113a031. J Med Chem. 1991. PMID: 1895306

4

Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.

Poulsen SA, Quinn RJ. Poulsen SA, et al. Among authors: quinn rj. J Med Chem. 1996 Oct 11;39(21):4156-61. doi: 10.1021/jm960052s. J Med Chem. 1996. PMID: 8863792

5

1-Phenylpyrazolo[3,4-d]pyrimidines as adenosine antagonists: the effects of substituents at C4 and C6.

Chebib M, Quinn RJ. Chebib M, et al. Among authors: quinn rj. Bioorg Med Chem. 1997 Feb;5(2):311-22. doi: 10.1016/s0968-0896(96)00240-4. Bioorg Med Chem. 1997. PMID: 9061196

6

Adenosine receptors: new opportunities for future drugs.

Poulsen SA, Quinn RJ. Poulsen SA, et al. Among authors: quinn rj. Bioorg Med Chem. 1998 Jun;6(6):619-41. doi: 10.1016/s0968-0896(98)00038-8. Bioorg Med Chem. 1998. PMID: 9681130 Review.

7

Diimidazo[1,2-c:4',5'-e]pyrimidines: adenosine agonist activity demonstrated by microphysiometry.

Camp D, Green JM, Kaiser SM, Moni RW, Townsend-Nicholson A, Schofield PR, Quinn RJ. Camp D, et al. Among authors: quinn rj. Bioorg Med Chem Lett. 1998 Mar 17;8(6):691-4. doi: 10.1016/s0960-894x(98)00102-4. Bioorg Med Chem Lett. 1998. PMID: 9871584

8

Diimidazo[1,2-c:4',5'-e]pyrimidines: N6-N1 conformationally restricted adenosines.

Camp D, Li Y, McCluskey A, Moni RW, Quinn RJ. Camp D, et al. Among authors: quinn rj. Bioorg Med Chem Lett. 1998 Mar 17;8(6):695-8. doi: 10.1016/s0960-894x(98)00101-2. Bioorg Med Chem Lett. 1998. PMID: 9871585

9

1-Phenylpyrazolo[3,4-d]pyrimidines; structure-ac:tivity relationships for C6 substituents at A1 and A2A adenosine receptors.

Chebib M, McKeveney D, Quinn RJ. Chebib M, et al. Among authors: quinn rj. Bioorg Med Chem. 2000 Nov;8(11):2581-90. doi: 10.1016/s0968-0896(00)00190-5. Bioorg Med Chem. 2000. PMID: 11092543

10

High-pressure synthesis of enantiomerically pure C-6 substituted pyrazol.

Poulsen SA, Young DJ, Quinn RJ. Poulsen SA, et al. Among authors: quinn rj. Bioorg Med Chem Lett. 2001 Jan 22;11(2):191-3. doi: 10.1016/s0960-894x(00)00620-x. Bioorg Med Chem Lett. 2001. PMID: 11206456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters